ArticleClinical and translational medicine2023

Multi-cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma.

Junya Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.